Your browser doesn't support javascript.
loading
New global reporting system for serious (product) events and adverse reactions in hematopoietic stem cell donation and transplantation.
Jöris, Monique; Pustjens, Esther; Mengling, Thilo; Fechter, Mirjam; Wiersum-Osselton, Johanna; Bokhorst, Arlinke; Foeken, Lydia.
Afiliación
  • Jöris M; World Marrow Donor Association, Leiden, The Netherlands. Monique.joris@wmda.info.
  • Pustjens E; World Marrow Donor Association, Leiden, The Netherlands.
  • Mengling T; DKMS gemeinnützige GmbH, Tübingen, Germany.
  • Fechter M; Matchis, Leiden, The Netherlands.
  • Wiersum-Osselton J; TRIP Hemovigilance and Biovigilance Office, Leiden, The Netherlands.
  • Bokhorst A; TRIP Hemovigilance and Biovigilance Office, Leiden, The Netherlands.
  • Foeken L; World Marrow Donor Association, Leiden, The Netherlands.
Cell Tissue Bank ; 22(2): 191-197, 2021 Jun.
Article en En | MEDLINE | ID: mdl-32902671
Annually more than 21,000 volunteer unrelated hematopoietic stem cell donations are performed worldwide for patients with life-threatening diseases such as acute leukaemia. Donor safety issues and donor protection is one of the top priorities for the international cooperation of unrelated hematopoietic stem cell donor registries represented by the World Marrow Donor Association (WMDA). With this new global reporting system for serious events and adverse reactions (S(P)EARs), the WMDA aims to become the global leading online platform for hematopoietic stem cell donor organisations to report their S(P)EARs from both unrelated and family donors. Software developer Cogapp developed the platform using a Knack environment based on requirements of experienced reporters and reviewers. On July 1st WMDA launched a robust online reporting system for S(P)EARs in order to provide accurate information about potential risks to donors. The collected data about S(P)EARs occurring in donors will be analysed and used to provide statistics on the type of reports being submitted and to put in place best practices to mitigate such effects and occurrences. Via the annual S(P)EAR reports the results will be disseminated worldwide.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Cell Tissue Bank Asunto de la revista: HISTOLOGIA / TRANSPLANTE Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Cell Tissue Bank Asunto de la revista: HISTOLOGIA / TRANSPLANTE Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Países Bajos